Zymeworks (ZYME) Amortization of Deferred Charges (2021 - 2026)

Zymeworks (ZYME) reported Amortization of Deferred Charges of $26000.0 for Q1 2026, down 96.32% on a YoY basis from $707000.0 in Q1 2025, and down 97.19% sequentially from $924000.0 in Q4 2025.

Zymeworks (ZYME) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of Amortization of Deferred Charges data on file, last reported at $26000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortization of Deferred Charges fell 96.32% year-over-year to $26000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 1.39% YoY), and the FY2025 full-year result was $3.4 million, up 34.91% from the prior year.
  • Amortization of Deferred Charges declined to $26000.0 in Q1 2026, from $924000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $3.5 million in Q3 2023 to a low of $26000.0 in Q1 2026.
  • A 5-year average of $1.0 million and a median of $690000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
  • Across the five-year window, Amortization of Deferred Charges soared 440.03% in 2023 and tumbled 96.32% in 2026, its largest moves.
  • Tracing ZYME's Amortization of Deferred Charges over 5 years: stood at $627000.0 in 2022, then soared by 81.66% to $1.1 million in 2023, then sank by 39.42% to $690000.0 in 2024, then soared by 33.91% to $924000.0 in 2025, then plunged by 97.19% to $26000.0 in 2026.
  • Business Quant data shows ZYME's Amortization of Deferred Charges at $26000.0 in Q1 2026, $924000.0 in Q4 2025, and $1.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Zymeworks 1.73 Bn 1.36 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 26,000.00
Mar 31, 2026 26,000.00
Dec 31, 2025 924,000.00
Dec 31, 2025 924,000.00
Sep 30, 2025 1.03 Mn
Sep 30, 2025 1.03 Mn
Jun 30, 2025 723,000.00
Jun 30, 2025 723,000.00
Mar 31, 2025 707,000.00
Mar 31, 2025 707,000.00
Dec 31, 2024 690,000.00
Dec 31, 2024 690,000.00
Sep 30, 2024 648,000.00
Sep 30, 2024 648,000.00
Jun 30, 2024 622,000.00
Jun 30, 2024 622,000.00
Mar 31, 2024 549,000.00
Mar 31, 2024 549,000.00
Dec 31, 2023 1.14 Mn
Dec 31, 2023 1.14 Mn